Topical application of phosphatidyl-inositol-3,5-bisphosphate for acute lung injury in neonatal swine

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 11, 2012, Pages 2813-2826

  Preuß, Stefanie ^a   Omam, Friede D ^a   Scheiermann, Julia ^a   Stadelmann, Sabrina ^a   Winoto Morbach, Supandi ^a   von Bismarck, Philipp ^a   Adam Klages, Sabine ^a   Knerlich Lukoschus, Friederike ^a   Lex, Dennis ^b   Wesch, Daniela ^a   Held Feindt, Janka ^a   Uhlig, Stefan ^b   Schütze, Stefan ^a   Krause, Martin F ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Apoptosis; Ceramide; Epithelial growth factors; Fibrosis; Macrophages

Indexed keywords

AMPHIREGULIN; CD14 ANTIGEN; CD18 ANTIGEN; CERAMIDE; GLYCOPROTEIN; IMIPRAMINE; INTERLEUKIN 6; LUNG SURFACTANT; PHOSPHATIDYLINOSITOL 3,5 DIPHOSPHATE; PHOSPHATIDYLINOSITOL 3,5-DIPHOSPHATE; POLYPHOSPHOINOSITIDE; SIGNAL PEPTIDE; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSFORMING GROWTH FACTOR BETA;

ACUTE LUNG INJURY; ANIMAL; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CELL MEMBRANE; CELL MOTION; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; LUNG LAVAGE; MACROPHAGE; METABOLISM; NEWBORN; PATHOLOGY; SWINE; TOPICAL DRUG ADMINISTRATION;

ACUTE LUNG INJURY; ADMINISTRATION, TOPICAL; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD14; ANTIGENS, CD18; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MEMBRANE; CELL MOVEMENT; CERAMIDES; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; IMIPRAMINE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MACROPHAGES; PHOSPHATIDYLINOSITOL PHOSPHATES; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; SPHINGOMYELIN PHOSPHODIESTERASE; SWINE; TRANSFORMING GROWTH FACTOR BETA;

SUIDAE;

EID: 84868090810     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01618.x     Document Type: Article

References (60)

1. Husari AW, Dbaibo GS, Bitar H, et al. Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia. Respir Res. 2006; 7: 100/1-11.
2. von Bismarck P, García Wistädt C-F, Klemm K, et al. Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model. Am J Respir Crit Care Med. 2008; 177: 1233-41.
3. Vivekananda J, Smith D, King RJ. Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP: phosphocholine cytidylyltransferase. Am J Physiol Lung Cell Mol Physiol. 2001; 281: L98-107.
4. Ryan AJ, McCoy DM, McGowan SE, et al. Aleveolar sphingolipids generated in response to TNF-alpha modifies surfactant biophysical properties. J Appl Physiol. 2003; 94: 253-8.
5. Göggel R, Winoto-Morbach S, Vielhaber G, et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med. 2004; 10: 155-60.
6. Heinrich M, Neumeyer J, Jakob M, et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and caspase-3 activation. Cell Death Differ. 2004; 11: 550-63.
7. Chan C, Goldkorn T. Ceramide path in human lung cell death. Am J Respir Cell Mol Biol. 2000; 22: 460-8.
8. Dove SK, Johnson ZE. Our fabulous vacation: a decade of phosphatidylinositol 3, 5-bisphosphate. Biochem Soc Symp. 2007; 74: 129-39.
9. Michell RH, Heath VL, Lemmon MA, et al. Phosphatidylinositol 3, 5-bisphosphate: metabolism and cellular functions. Trends Biochem Sci. 2006; 31: 52-63.
10. Kölzer M, Arenz C, Ferlinz K, et al. Phosphatidylinositol-3, 5-bisphosphate is a potent and selective inhibitor of acid sphingomyelinase. Biol Chem. 2003; 384: 1293-8.
11. Roth AG, Drescher D, Yang Y, et al. Potent and selective inhibition of acid sphingomyelinase by bisphosphonates. Angew Chem Int Ed. 2009; 48: 7560-3.
12. Krause MF, Jäkel C, Haberstroh J, et al. Alveolar recruitment promotes homogeneous surfactant distribution in a piglet model of lung injury. Pediatr Res. 2001; 50: 34-43.
13. Claus RA, Bunck AC, Bockmeyer CL, et al. Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J. 2005; 19: 1719-21.
14. Tellmann G. The E-method: a highly accurate technique for gene-expression analysis. Nat Meth. 2006; 3. Published online 21 June 2006. doi: 10.1038/NMETH894.
15. Wiegmann K, Schütze S, Machleidt T, et al. Functional dichotomy of neutral and acidic sphingomyelinase in tumor necrosis factor signaling. Cell. 1994; 78: 1005-15.
16. Jensen JM, Schütze S, Förl M, et al. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest. 1999; 104: 1761-70.
17. Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L601-11.
18. Engle WA, Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008; 121: 419-32.
19. Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. JAMA. 2005; 293: 470-6.
20. Spragg RG, Taut FJ, Lewis JF, et al. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med. 2011; 183: 1055-61.
21. Simons K, Ikonen E. How cells handle cholesterol. Science. 2000; 290: 1721-6.
22. Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest. 2002; 110: 3-8.
23. Prinetti A, Chigorno V, Prioni S, et al. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cellular granule cells developing in vitro. J Biol Chem. 2001; 276: 21136-45.
24. Longo CA, Tyler D, Mallampalli RK. Sphingomyelin metabolism is developmentally regulated in rat lung. Am J Respir Cell Mol Biol. 1997; 16: 605-12.
25. Wynn JL, Cvijanovich NZ, Allen GL, et al. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med. 2011; 17: 1146-56.
26. Nussbaum C, Sperandio M. Innate immune cell recruitment in the fetus and neonate. J Reprod Immunol. 2011; 90: 74-81.
27. Takahashi I, Takahashi T, Abe T, et al. Distribution of acid sphingomyelinase in human various body fluids. Tohoku J Exp Med. 2000; 192: 61-6.
28. Xu Y, Seet L-F, Hanson B, et al. The Phox homology (PX) domain, a new player in phosphoinositide signalling. Biochem J. 2001; 360: 513-30.
29. Spyridakis S, Leondaritis G, Nakos G, et al. A specific phospholipase C activity regulates phosphatidylinositol levels in lung surfactant of patients with acute respiratory distress syndrome. Am J Respir Cell Mol Biol. 2010; 42: 357-62.
30. Duex JE, Nau JJ, Kauffman EJ, et al. Phosphoinositide 5-phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced phosphatidylinositol 3, 5-bisphosphate levels. Eucaryot Cell. 2006; 5: 723-31.
31. Bern RA, van der Loss CM, van Woensel JBM, et al. Cleaved caspase-3 in lung epithelium of children who died with acute respiratory distress syndrome. Pediatr Crit Care Med. 2010; 11: 556-60.
32. del Riccio V, van Tuyl M, Post M. Apoptosis in lung development and neonatal lung injury. Pediatr Res. 2004; 55: 183-9.
33. Martin TR, Hagimoto N, Nakamura M, et al. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc. 2005; 2: 214-20.
34. Edwards YS, Sutherland LM, Power JHT, et al. Cyclic stretch induces both apoptosis and secretion in rat alveolar type II cells. FEBS Lett. 1999; 448: 127-30.
35. Kitamura Y, Hashimoto S, Mizuta N, et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med. 2001; 163: 762-9.
36. Edelmann B, Bertsch U, Tchikov V, et al. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J. 2011; 30: 379-94.
37. Matute-Bello G, Martin TR. Science review: apoptosis in acute lung injury. Crit Care. 2003; 7: 355-8.
38. Takemura Y, Iwasaki Y, Nagata K, et al. Influence of depletion of alveolar macrophages on apoptosis in Candida-induced acute lung injury. Exp Lung Res. 2005; 31: 307-21.
39. Petrusca DN, Gu Y, Adamowicz JJ, et al. Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages. J Biol Chem. 2010; 285: 40322-32.
40. Lucas R, Verin AD, Black SM, et al. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol. 2009; 77: 1763-72.
41. Maus U, Herold S, Muth H, et al. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L58-68.
42. Frevert CW, Matute-Bello G, Skerrett SJ, et al. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol. 2000; 164: 5439-45.
43. Yamamoto T, Kajikawa O, Martin TR, et al. The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits. J Immunol. 1998; 161: 5704-9.
44. Reiss LK, Uhlig U, Uhlig S. Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol. 2012; 91: 590-601.
45. Dolinay T, Kaminski N, Felgendreher M, et al. Gene expression profiling of target genes in ventilator-induced lung injury. Physiol Genomics. 2006; 26: 68-75.
46. Spieth PM, Carvalho AR, Pelosi P, et al. Variable tidal volumes improve lung protective ventilation strategies in experimental lung injury. Am J Respir Crit Care Med. 2009; 179: 684-93.
47. Chen H-H, Zhao S, Song J-G. TGF-β1 suppresses apoptosis via differential regulation of MAP kinases and ceramide production. Cell Death Differ. 2003; 10: 516-27.
48. Fahy RJ, Lichtenberger F, McKeegan CB, et al. The acute respiratory distress syndrome. A role for transforming growth factor-1β. Am J Respir Cell Mol Biol. 2003; 28: 499-503.
49. Budinger GRS, Chandel NS, Donnelly HK, et al. Active transforming growth factor-β1 activates the procollagen I promotor in patients with acute lung injury. Intensive Care Med. 2005; 31: 121-8.
50. Pekary AE, Hershman JM. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I-symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology. 1998; 139: 703-12.
51. Santiago VR, Rzezinski AF, Nardelli LM, et al. Recruitment maneuver in experimental acute lung injury: the role of alveolar collapse and edema. Crit Care Med. 2010; 38: 2207-14.
52. Birukova AA, Tian Y, Meliton AY, et al. Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6. Am J Physiol Lung Cell Mol Physiol. 2012; 302: L965-75.
53. Peng X, Mathai SK, Murray LA, et al. Local apoptosis promotes collagen production by monocyte-driven cells in transforming growth factor β1-induced lung fibrosis. Fibrogenesis Tissue Repair. 2011; 4: 12-25.
54. Sparkman L, Chandru H, Boggaram V. Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activity. Am J Physiol Lung Cell Mol Physiol. 2006; 290: L351-8.
55. Lindner L, Uhlig U, Uhlig S. Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. Br J Pharmacol. 2005; 145: 132-40.
56. Yang J, Qu J, Summah H, et al. Protective effects of imipramine in murine endotoxin-induced acute lung injury. Eur J Pharmacol. 2010; 638: 128-33.
57. Preuß S, Stadelmann S, Omam FD, et al. Inositol-trisposphate reduces alveolar apoptosis and pulmonary edema in neonatal lung injury. Am J Respir Cell Mol Biol. 2012; 47: 158-69.
58. Ikegami M, Dhami R, Schuchman EH. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am J Physiol Lung Cell Mol Physiol. 2003; 284: L518-25.
59. Zhang Y, Duan R-D. Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells. Lipids Health Dis. 2009; 8: 51.
60. Lara LS, Correa JS, Lavelle AB, et al. The angiotensin receptor type 1-Gq protein-phosphatidylinositol phospholipase Cβ-protein kinase C pathway is involved in activation of proximal tubule Na+-ATPase activity by angiotensin(1-7) in pig kidneys. Exp Physiol. 2008; 93: 639-47.